West Daniel C, Romano Patrick S, Azari Rahman, Rudominer Andrea, Holman Mark, Sandhu Surdip
Department of Pediatrics, School of Medicine, University of California, Davis 95817, USA.
Arch Pediatr Adolesc Med. 2003 Dec;157(12):1197-201. doi: 10.1001/archpedi.157.12.1197.
Parallels between the biological effects of exposure to environmental tobacco smoke (ETS) on nonsmokers and the pathophysiology of sickle cell disease (SCD) suggest that complications of SCD could be exacerbated by ETS exposure.
To determine whether children with SCD who are exposed to ETS at home have more sickle cell crises than do those who live in nonsmoking households.
A retrospective cohort study in which ETS exposure was measured by using a survey of caretakers and patients.
A university-based pediatric sickle cell center.
Fifty-two of 66 eligible children aged 2 to 18 years with SCD.
The number of sickle cell vaso-occlusive crises requiring hospitalization per patient during the 2-year study (inpatient sickle cell crises). Total hospital days and hospital costs were secondary outcome measures.
Patients exposed to ETS had more inpatient sickle cell crises than did unexposed patients (mean +/- SD, 3.7 +/- 5.7 vs 1.7 +/- 3.5; P =.02), and this association retained significance after adjustment for important covariates (risk ratio, 1.9; 95% confidence interval, 1.3-2.7). Hospital costs were greater in the exposed group than in the unexposed group (mean +/- SD, 21,671 US dollars +/- 41,809 US dollars vs 9705 US dollars +/- 19 146 US dollars; effect estimate, 11.4; 95% confidence interval, 1.0-129.5).
Children with SCD who are exposed to ETS have a higher risk of sickle cell crises requiring hospitalization than do those not exposed, independent of other factors known to increase the frequency of sickle cell crises. Decreasing the exposure of these children to ETS could reduce morbidity and may provide cost savings.
接触环境烟草烟雾(ETS)对非吸烟者产生的生物学效应与镰状细胞病(SCD)的病理生理学之间存在相似之处,这表明接触ETS可能会加剧SCD的并发症。
确定家中接触ETS的SCD儿童是否比生活在无烟家庭中的儿童发生更多镰状细胞危象。
一项回顾性队列研究,通过对看护者和患者进行调查来测量ETS暴露情况。
一家大学附属儿科镰状细胞中心。
66名2至18岁符合条件的SCD儿童中的52名。
在为期2年的研究期间,每位患者需要住院治疗的镰状细胞血管阻塞性危象的数量(住院镰状细胞危象)。总住院天数和住院费用为次要观察指标。
接触ETS的患者比未接触的患者发生更多住院镰状细胞危象(均值±标准差,3.7±5.7对1.7±3.5;P = 0.02),在对重要协变量进行调整后,这种关联仍具有显著性(风险比,1.9;95%置信区间,1.3 - 2.7)。暴露组的住院费用高于未暴露组(均值±标准差,21,671美元±41,809美元对9,705美元±19,146美元;效应估计值,11.4;95%置信区间,1.0 - 129.5)。
接触ETS的SCD儿童比未接触的儿童发生需要住院治疗的镰状细胞危象的风险更高,这独立于其他已知会增加镰状细胞危象发生频率的因素。减少这些儿童接触ETS的情况可能会降低发病率,并可能节省成本。